Rituximab in rheumatology: single-centre SARS-CoV-2 infection and COVID-19 prevalence.
Lever E, Colquhoun M, Flora K, El-Ghazali S, Baslas R, Suleman Y, Wieckowski A, Farah Z, Hamdulay S, Isaacs A, Mukherjee J, Pazos F, Penn H, Machado PM.
Lever E, et al. Among authors: farah z.
Rheumatol Adv Pract. 2022 Mar 10;6(1):rkac009. doi: 10.1093/rap/rkac009. eCollection 2022.
Rheumatol Adv Pract. 2022.
PMID: 35350718
Free PMC article.
No abstract available.